Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2011

01-01-2011 | Original paper

Age and HIV Sexual Risk among Women in Methadone Treatment

Authors: Malitta Engstrom, Tazuko Shibusawa, Nabila El-Bassel, Louisa Gilbert

Published in: AIDS and Behavior | Issue 1/2011

Login to get access

Abstract

This study examines the relationship between age and HIV sexual risk behaviors among a random sample of 372 women in methadone treatment in New York City. Logistic regression results indicate that women of all ages are at risk for HIV through inconsistent condom use. Exposure to intimate partner violence (IPV), alcohol use, and HIV-negative status are associated with inconsistent condom use during vaginal sex. Age (35–44), having a main sexual partner with an HIV risk factor, IPV, and alcohol use are associated with using crack or cocaine during sex. Similarly, age (35–44), having a main sexual partner with an HIV risk factor, IPV, and drug use are associated with consuming four or more drinks prior to sex. The findings highlight the importance of age-appropriate HIV prevention and intervention strategies, as well as the need to address intimate partner violence, mental health, polysubstance use, and relational factors associated with HIV sexual risk behaviors among women in methadone treatment.
Literature
1.
2.
Mack KA, Ory MG. AIDS and older Americans at the end of the twentieth century. J Acquir Immune Defic Syndr. 2003;33(S2):S68–75.PubMed
3.
Centers for Disease Control and Prevention. Subpopulation estimates from the HIV incidence surveillance system—United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(36):985–9.
4.
Centers for Disease Control and Prevention. MMWR analysis provides new detail on HIV incidence in U.S. populations. CDC HIV/AIDS Facts, September 2008.
5.
Kwiatkowski CF, Booth RE. HIV risk behaviors among older American drug users. J Acquir Immune Defic Syndr. 2003;33:S131–7.PubMed
6.
Tuchman E. Methadone and menopause: the aging population of women in drug treatment. J Soc Work Pract Addict. 2003;3(2):14–26.
7.
Weeks MR, Singer M, Schensul JJ, Jia Z, Grier M. Project COPE: preventing AIDS among injection drug users and their sex partners: descriptive data report. Hartford, CT: Institute for Community Research; 1993.
8.
Weeks MR, Singer M, Himmelgreen DA, et al. Drug use patterns of substance abusing women: gender and ethnic differences in an AIDS prevention program. Drugs Soc. 1998;13(1/2):35–61.CrossRef
9.
Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO study). J Urban Health. 2003;80(1):137–46.CrossRefPubMed
10.
Fernando D, Schilling RF, Fontdevila J, El-Bassel N. Predictors of sharing drugs among injection drug users in the South Bronx: implications for HIV transmission. J Psychoactive Drugs. 2003;35(2):227–36.PubMed
11.
Iguchi MY, Bux DA, Kushner H, Lidz V. Correlates of HIV risk among female sex partners of injecting drug users in a high-seroprevalence area. Eval Program Plann. 2001;24(2):175–85.CrossRef
12.
Krauss BJ, Wolitski RJ, Tross S, Corby NH, Fishbein M. Getting the message: HIV information sources of women who have sex with injecting drug users: a two-site study. J Appl Psychol. 1999;48(2):153–73.
13.
Deren S, Davis R, Tortu S, Ahluwahlia I. Characteristics of female sexual partners. In: Brown B, Beschner B, editors. Handbook on risk for AIDS: injection drug users and sexual partners. Westport, CT: Greenwood Press; 1993.
14.
Corsi KF, Kwiatkowski CF, Booth RE. Long-term predictors of HIV risk behaviors among IDUs. J Drug Issues. 2006;36(3):649–66.
15.
Fullilove MT, Lown EA, Fullilove RE. Crack “hos and skeezers”: traumatic experiences of women crack users. J Sex Res. 1992;29:275–87.CrossRef
16.
Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women’s involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 2000;58:227–36.CrossRefPubMed
17.
Edwards JM, Halpern CT, Wechsberg WM. Correlates of exchanging sex for drugs or money among women who use crack cocaine. AIDS Educ Prev. 2006;18(5):420–9.CrossRefPubMed
18.
Longshore D, Anglin MD. Number of sex partners and crack cocaine use: is crack an independent marker for HIV risk behavior? J Drug Issues. 1995;25:1–10.
19.
Wingood GM, DiClemente RJ. The influence of psychosocial factors, alcohol, drug use on African-American women’s high-risk sexual behavior. Am J Prev Med. 1998;15(1):54–9.CrossRefPubMed
20.
Stevens SJ, Estrada AL, Estrada BD. HIV sex and drug risk behavior and behavior change in a national sample of injection drug and cocaine using women. Women Health. 1998;27(1/2):25–48.PubMed
21.
Levy JA. AIDS and injecting drug use later in life. Res Aging. 1998;20(6):776–97.CrossRef
22.
Zablotsky D. Overlooked, ignored, and forgotten: older women at risk for HIV infection and AIDS. Res Aging. 1998;20(6):760–75.CrossRef
23.
Zablotsky D, Kennedy M. Risk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practices. J Acquir Immune Defic Syndr. 2003;33:S122–30.PubMed
24.
Hartel DM, Schoenbaum EE, Lo Y, Klein RS. Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis. 2006;43:525–31.CrossRefPubMed
25.
Hser Y-I, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503–8.CrossRefPubMed
26.
Johnson SD, Striley C, Cottler LB. Cormorbid substance use and HIV risk in older African American drug users. J Aging Health. 2007;19(4):646–58.CrossRefPubMed
27.
Staton M, Walker R, Leukefeld C. Age differences in risk behavior among incarcerated substance-abusing women. J Addict Nurs. 2003;3-9:14.
28.
Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend. 1999;54:83–6.CrossRefPubMed
29.
Substance Abuse and Mental Health Services Administration Office of Applied Studies. Results from the 2007 national survey on drug use and health: national findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD; 2008.
30.
Valliant GE. A long-term follow-up of male alcohol abuse. Arch Gen Psychiatry. 1996;53:243–9.
31.
Schensul JJ, Levy JA, Disch WB. Individual, contextual, and social network factors affecting exposure to HIV/AIDS risk among older residents living in low-income senior housing complexes. J Acquir Immune Defic Syndr. 2003;33:S138–52.PubMed
32.
Diokno AC, Brown MB, Herzog AR. Sexual function in the elderly. Arch Intern Med. 1990;150(1):197–200.CrossRefPubMed
33.
Lindau ST, Schumm P, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762–74.CrossRefPubMed
34.
Somlai AM, Kelly JA, McAuliffe TL, Ksobiech K, Hackl KL. Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women. AIDS Behav. 2003;7(4):383–93.CrossRefPubMed
35.
Richard AJ, Bell DC, Montoya ID. Age and HIV risk in a national sample of injection drug and crack cocaine users. Subst Use Misuse. 2000;35(10):1385–404.CrossRefPubMed
36.
El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone maintained women in New York City. Soc Sci Med. 2005;61:171–83.CrossRefPubMed
37.
El-Bassel N, Cooper D, Chen D. Social support and social networks among women on methadone. Soc Serv Rev. 1998;72:379–401.CrossRef
38.
Schilling RF, El-Bassel N, Gilbert L, Glassman M. Predictors of changes in sexual behavior among women on methadone. Am J Drug Alcohol Abuse. 1993;19(4):409–22.CrossRefPubMed
39.
Semaan S, Kotranski L, Collier K, et al. Temporal trends in HIV risk behaviors among out-of-treatment women crack users: the need for drug treatment. Drugs Soc. 1998;13(12):13–33.CrossRef
40.
Wechsberg WM, Cavanaugh ER. Differences found between women injectors in and out of treatment: implications for interventions. Drugs Soc. 1998;13(1/2):63–79.CrossRef
41.
Theall KP, Elifson KW, Sterk CE, Klein H. Perceived susceptibility to HIV among women: differences in age. Res Aging. 2003;25(4):405–32.CrossRef
42.
Sterk CE, Elifson KW, Theall KP. Women and drug treatment experiences: a generational comparison of mothers and daughters. J Drug Issues. 2000;30(4):839–62.
43.
Grella CE, Anglin MD, Annon JJ. HIV risk behaviors among women in methadone treatment. Subst Use Misuse. 1996;31(3):277–301.CrossRefPubMed
44.
El-Bassel N, Gilbert L, Krishnan S, et al. Partner violence and sexual HIV-risk behaviors among women in an inner-city emergency department. Violence Vict. 1998;13(4):377–93.PubMed
45.
Gilbert L, El-Bassel N, Schilling RF, Wada T, Bennet B. Partner violence and sexual HIV risk behaviors among women in methadone treatment. AIDS Behav. 2000;4(3):261–9.CrossRef
46.
Wu E, El-Bassel N, Witte SS, Gilbert L, Chang M. Intimate partner violence and HIV risk among urban minority women in primary health care settings. AIDS Behav. 2003;7(3):291–301.CrossRefPubMed
47.
Hutton HE, Treisman GJ, Hunt WR, et al. HIV risk behaviors and their relationship to posttraumatic stress disorder among women prisoners. Psychiatr Serv. 2001;52(4):508–13.CrossRefPubMed
48.
Wyatt GE, Myers HF, Williams JK, et al. Does a history of trauma contribute to HIV risk for women of color? Implications for prevention and policy. Am J Public Health. 2002;92(4):660–5.CrossRefPubMed
49.
Paxton KC, Myers HF, Hall NM, Javanbakht M. Ethnicity, serostatus, and psychosocial differences in sexual risk behavior among HIV-seropositive and HIV-seronegative women. AIDS Behav. 2004;8(4):405–15.CrossRefPubMed
50.
Schönnesson LN, Atkinson J, Williams ML, et al. A cluster analysis of drug use and sexual HIV risks and their correlates in a sample of African-American crack cocaine smokers with HIV infection. Drug Alcohol Depend. 2008;97:44–53.CrossRefPubMed
51.
Friedman S, Chapman TF, Perlis TE, et al. Modulators of “activated motivation”: event-specific condom use by drug injectors who have used condoms to prevent HIV/AIDS. AIDS Behav. 1999;3:85–98.CrossRef
52.
Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.CrossRefPubMed
53.
Dolezal C, Ehrhardt AA, Meyer-Bahlburg HFL, et al. Sexual risk behavior changes among HIV+ and HIV− female injecting drug users over 4 years. Women Health. 1998;27(4):1–17.CrossRefPubMed
54.
Dixon DA, Antoni M, Peters M, Saul J. Employment, social support and HIV sexual-risk behavior in Puerto Rican women. AIDS Behav. 2001;54(4):331–42.CrossRef
55.
El-Bassel N, Schilling RF. Social support and sexual risk taking among women on methadone. AIDS Educ Prev. 1994;6(6):506–13.PubMed
56.
Miller M, Paone D. Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Soc Sci Med. 1998;47(6):765–77.CrossRefPubMed
57.
Sobo EJ. Finance, romance, social support, and condom use among impoverished inner-city women. Hum Organ. 1995;54(2):115–28.
58.
Levy JA, Holmes D, McKenzie S. Conceptual and methodological issues in research on age and aging. J Acquir Immune Defic Syndr. 2003;33:S206–17.CrossRefPubMed
59.
Derogatis LR. Brief symptom inventory: administration, scoring, and procedures manual. Minneapolis: National Computer Systems; 1993.
60.
Foa EB. Posttraumatic stress diagnostic scale manual. Minneapolis: National Computer Systems; 1995.
61.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
62.
Straus M, Hamby S, Boney-McCoy S, Sugarman D. The revised Conflict Tactics Scale (CTS2): development and preliminary psychometric data. J Fam Issues. 1996;17(3):283–316.CrossRef
63.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52:30–41.CrossRef
64.
StataCorp. Stata statistical software: release 10. College Station, TX: StataCorp LP; 2007.
65.
Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.CrossRef
66.
Schafer J. Analysis of incomplete multivariate data. London: Chapman & Hall; 1997.CrossRef
67.
Sormanti M, Shibusawa T. Predictors of condom use and HIV testing among midlife and older women seeking medical services. J Aging Health. 2007;19(4):705–19.CrossRefPubMed
68.
Tawk H, Simpson J, Mindel A. Condom use in multi-partnered females. Int J STD AIDS. 2004;15(6):403–7.CrossRefPubMed
69.
Miller S, Exner TM, Williams SP, Ehrhardt AA. A gender specific intervention for at-risk women. AIDS Care. 2000;12(5):603–12.CrossRefPubMed
70.
Sikkema KJ, Kelly JA, Winett RA, et al. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low income housing developments. Am J Public Health. 2000;90(1):57–64.CrossRefPubMed
71.
El-Bassel N, Witte SS, Gilbert L, et al. The efficacy of a relationship-based HIV/STD prevention program for heterosexual couples. Am J Public Health. 2003;93:963–9.CrossRefPubMed
72.
Auerbach JD, Coates TJ. HIV prevention research: accomplishments and challenges for the third decade of AIDS. Am J Public Health. 2000;90:1029–32.CrossRefPubMed
73.
Wechsberg WM, Craddock SG, Hubbard RL. How are women who enter substance abuse treatment different than men? A gender comparison from the drug abuse treatment outcome study. Drugs Soc. 1998;13(1–2):97–115.CrossRef
74.
Amaro H. Love, sex, and power: considering women’s realities in HIV prevention. Am Psychol. 1995;50(6):437–47.CrossRefPubMed
75.
Fordyce EJ, Blum S, Balanon A, Stoneburner RL. A method for estimating HIV transmission rates among female sex partners of male intravenous drug users. Am J Epidemiol. 1991;133:590–8.PubMed
76.
Wagstaff DA, Kelly JA, Perry MJ, et al. Multiple partners, risky partners and HIV risk among low-income urban women. Fam Plann Perspect. 1995;27(6):241–5.CrossRefPubMed
77.
Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 2004;74(3):265–72.CrossRefPubMed
78.
Engstrom M, El-Bassel N, Go H, Gilbert L. Childhood sexual abuse and intimate partner violence among women in methadone treatment: a direct or mediated relationship? J Fam Violence. 2008;23(7):605–17.CrossRef
79.
McLellan AT, Hagan TA, Levine M, et al. Supplemental social services improve outcomes in public addiction treatment. Addiction. 1998;93(10):1489–99.CrossRefPubMed
80.
Marsh JC, Dingcai C, D’Aunno T. Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abuse Treat. 2004;27:289–300.CrossRefPubMed
81.
Grella CE, Stein JA. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders. Psychiatr Serv. 2006;57(7):1007–15.CrossRefPubMed
82.
Schiff M, El-Bassel N, Engstrom M, Gilbert L. Psychological distress and intimate physical and sexual abuse among women in methadone maintenance treatment programs. Soc Serv Rev. 2002;76(2):302–20.CrossRef
83.
Hien DA, Nunes E, Levin FR, Fraser D. Posttraumatic stress disorder and short-term outcome in early methadone treatment. J Subst Abuse Treat. 2000;19:31–7.CrossRefPubMed
84.
Morrissey JP, Jackson EW, Ellis AR, et al. Twelve-month outcomes of trauma-informed interventions for women with co-occurring disorders. Psychiatr Serv. 2005;56(10):1213–22.CrossRefPubMed
85.
Finkelstein N, VandeMark N, Fallot R, et al. Enhancing substance abuse recovery through integrated trauma treatment. Sarasota, FL: The National Trauma Consortium; 2004.
86.
Amaro H, McGraw S, Larson MJ, et al. Boston consortium of services for families in recovery: a trauma-informed intervention model for women’s alcohol and drug addiction treatment. Alcohol Treat Q. 2004;22(3–4):95–119.
87.
Hien DA, Cohen LR, Miele GM, Litt LC, Capstick C. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004;161(8):1426–32.CrossRefPubMed
88.
Ducharme LJ, Mello HL, Roman PM, Knudsen HK, Johnson JA. Service delivery in substance abuse treatment: reexamining “comprehensive” care. J Behav Health Serv Res. 2007;34(2):121–36.CrossRefPubMed
89.
Friedman PD, Lemon S, Durkin EM, D’Aunno T. Trends in comprehensive service availability in outpatient drug abuse treatment. J Subst Abuse Treat. 2003;24:81–8.CrossRef
90.
McFarland BH, Gabriel RM. Service availability for persons with co-occurring conditions. Psychiatr Serv. 2004;55(9):978.CrossRefPubMed
91.
Mojtabai R. Which substance abuse treatment facilities offer dual diagnosis programs? Am J Drug Alcohol Abuse. 2004;30(3):525–36.CrossRefPubMed
Metadata
Title
Age and HIV Sexual Risk among Women in Methadone Treatment
Authors
Malitta Engstrom
Tazuko Shibusawa
Nabila El-Bassel
Louisa Gilbert
Publication date
01-01-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9625-z

Other articles of this Issue 1/2011

AIDS and Behavior 1/2011 Go to the issue

OriginalPaper

Cigarette Smoking and Mortality Among HIV-Infected Individuals in Seattle, Washington (1996–2008)

Original Paper

Alcohol Consumption is Associated with Poor Health in HIV Clinic Patient Population: A Behavioral Surveillance Study

Original paper

Injection Drug Use as a Mediator Between Client-perpetrated Abuse and HIV Status Among Female Sex Workers in Two Mexico-US Border Cities

ORIGINAL PAPER

Sexual Mixing and Condom Use with Different Types of Sex Partners among Non-Institutionalized Sexually Active Female Injecting Drug Users in Sichuan, China

Original Paper

History of Sexual Trauma and Recent HIV-Risk Behaviors of Community-Recruited Substance Using Women

Erratum

Erratum to: Alcohol and Risky Sexual Behavior Among Heavy Drinking College Students
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits